Sonoma Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

9. Segment and Geographic Information (Details) - USD ($)	3 Months Ended
	Jun. 30, 2018	Jun. 30, 2017
Revenues	$ 4,369,000	$ 3,835,000
Product [Member]
Revenues	4,095,000	3,603,000
Product [Member] \| UNITED STATES
Revenues	1,971,000	1,859,000
Product [Member] \| Latin America [Member]
Revenues	1,079,000	569,000
Product [Member] \| Europe and Rest of the World [Member]
Revenues	$ 1,045,000	$ 1,175,000